GO:0180058 protein co-translational transfer of dolichol-linked oligosaccharide

Protein co-translational transfer of dolichol-linked oligosaccharide (GO:0180058) is a biological process that defines the en bloc transfer of a preassembled lipid-linked oligosaccharide (LLO) precursor to an asparagine residue within the consensus sequence Asn-X-Ser/Thr of a nascent polypeptide. This reaction occurs in the lumen of the endoplasmic reticulum (ER) and is catalyzed by the oligosaccharyltransferase (OST) complex, which is associated with the translocon and acts on the growing polypeptide chain as it emerges into the ER. The term is synonymous with protein N-linked glycosylation via asparagine, co-translational, and is a critical step in the N-linked glycosylation pathway. N-linked glycosylation is one of the most common and complex post-translational modifications in eukaryotic cells, influencing protein folding, stability, trafficking, and function. The co-translational nature of the transfer ensures that glycosylation occurs early in the protein life cycle, often co-incident with translocation, which is essential for proper glycoprotein maturation. Defects in this process can lead to a range of human diseases, including congenital disorders of glycosylation (CDGs), and can affect the efficacy of therapeutic glycoproteins. For researchers, GO:0180058 provides a precise ontological framework to study the molecular machinery, regulation, and physiological impact of N-linked glycosylation. Understanding the factors that control site occupancy and glycan heterogeneity is crucial for basic biology and for the development of biotherapeutics.

GO:0180058 is defined as an N-linked protein glycosylation process in which the preassembled dolichol-linked oligosaccharide precursor is transferred post-translationally to an asparagine residue within the motif Asn-X-Ser/Thr of the target protein, mediated by the OSTA complex. In simpler terms, it is the co-translational attachment of a sugar tree to a newly made protein, a key step in N-linked glycosylation.

GO:0180058 is fundamentally important because N-linked glycosylation is essential for the proper folding, stability, and function of a vast number of secretory and membrane proteins. The co-translational transfer of the LLO precursor ensures that glycans are attached early during protein synthesis, which is critical for glycoprotein quality control in the ER. Dysregulation of this process can lead to protein misfolding, ER stress, and a variety of human diseases, including congenital disorders of glycosylation and cancer. Moreover, the efficiency of this reaction directly impacts the production of recombinant therapeutic glycoproteins, where consistent glycosylation is required for drug safety and efficacy.

The following genes and proteins are key components or regulators of the protein co-translational transfer of dolichol-linked oligosaccharide process.

The co-translational transfer of dolichol-linked oligosaccharide is regulated at multiple levels. The availability of the LLO substrate is controlled by the expression and activity of enzymes in the dolichol pathway. The OST complex itself is regulated by subunit composition and abundance; for example, STT3A and STT3B form distinct complexes with different substrate specificities. Translation speed and the local sequence context around the sequon influence the probability of glycosylation. Additionally, cellular stress pathways such as the unfolded protein response (UPR) can modulate glycosylation capacity to cope with increased protein folding demand. While specific transcription factors like mTOR or ISR are not directly implicated in the QuickGO definition, general cellular metabolism and stress responses can impact this process.

Mutations in genes involved in the synthesis of the dolichol-linked oligosaccharide or in the OST complex cause a group of rare inherited diseases known as congenital disorders of glycosylation (CDGs). These disorders typically present with multisystem symptoms including developmental delay, seizures, and coagulopathies. For example, mutations in ALG genes (ALG1, ALG2, ALG3, etc.) lead to defective LLO assembly and reduced glycosylation site occupancy, resulting in CDG type I. Similarly, defects in OST subunits such as DDOST or MAGT1 can cause CDG or immunodeficiency.

Altered N-linked glycosylation is a common feature of cancer cells and contributes to tumor growth, invasion, and metastasis. Changes in the expression of glycosyltransferases and OST subunits can lead to aberrant glycosylation patterns that promote oncogenic signaling and immune evasion. For instance, increased expression of STT3A or STT3B has been observed in some cancers and is associated with poor prognosis. Targeting the glycosylation machinery is being explored as a therapeutic strategy.

Proper glycosylation is essential for immune cell function and the production of immunoglobulins. Mutations in MAGT1, an OST accessory subunit, cause a primary immunodeficiency characterized by impaired T cell function and susceptibility to infections. This highlights the critical role of co-translational glycosylation in the immune system.

Mass spectrometry is a powerful method to identify glycosylation sites and quantify site occupancy on a global scale. By enriching glycopeptides, researchers can map N-linked glycosylation sites and determine the extent of occupancy, providing insights into the regulation of GO:0180058. This method is widely used to study changes in glycosylation in disease models and therapeutic protein production.

Mutating the Asn-X-Ser/Thr sequon to prevent glycosylation, or introducing new sequons, allows researchers to study the impact of individual glycosylation sites on protein function and stability. Reporter proteins with engineered sequons can be used to assess the efficiency of co-translational transfer in different cellular conditions.

Small molecule inhibitors such as tunicamycin block the formation of LLO precursors, leading to global inhibition of N-linked glycosylation. These inhibitors are useful to study the consequences of glycosylation loss and to validate the role of specific glycans.

CRISPR-Cas9 allows the generation of knockout, knock-in, or point-mutant cell lines for genes involved in GO:0180058. This approach enables functional studies of OST subunits and LLO synthesis enzymes in a physiologically relevant context.

Researchers studying protein co-translational transfer of dolichol-linked oligosaccharide-related genes often need to determine whether a candidate gene is causally involved in glycosylation, how mutations affect site occupancy, and whether targeting the pathway can modify disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and scale.

GO:0180058, protein co-translational transfer of dolichol-linked oligosaccharide, is a central step in N-linked glycosylation that ensures proper protein folding and function. Its dysregulation is linked to a spectrum of human diseases, making it a vital area of research. Advances in CRISPR-based models and glycoproteomics are accelerating our understanding of this process and its therapeutic potential. EDITGENE offers a comprehensive toolkit to investigate this pathway, from gene knockout to precise point mutations, empowering researchers to uncover new biology and develop novel treatments.